Forkhead Transcription Factor Regulation in Cancer Cell Biology

Forkhead transcription factors of the FOXO subfamily are pivotal regulators of cancer cell fate, integrating signals from growth factors, nutrient sensors and stress pathways to control gene networks for proliferation, apoptosis, DNA repair and metabolism. The core mechanism involves modulation of FOXO subcellular localisation by post-translational modifications—principally phosphorylation by the PI3K/AKT and MAPK pathways, acetylation by histone acetyltransferases and deacetylation by sirtuins, and ubiquitination. In quiescent cells or under stress, unmodified FOXOs accumulate in the nucleus, where they bind conserved forkhead response elements to upregulate cell cycle inhibitors, pro-apoptotic genes such as BIM and regulators of oxidative stress. In many cancers, oncogenic activation of AKT or ERK promotes FOXO phosphorylation, cytoplasmic sequestration and degradation, thereby disabling tumour-suppressive programmes. Conversely, therapeutic inhibition of these kinases or modulation of acetylation status can restore FOXO activity and trigger growth arrest or cell death. FOXOs also govern metastatic potential by regulating epithelial-mesenchymal transition factors and angiogenic programmes, while cross-talk with energy sensors such as AMP-activated protein kinase links metabolic stress to transcriptional reprogramming. The broad impact of FOXO regulation extends from tumour initiation to treatment resistance, highlighting these factors as both biomarkers and drug targets in diverse malignancies.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Forkhead Transcription Factor Regulation in Cancer Cell Biology publication trend

The graph below shows the total number of articles in forkhead transcription factor regulation in cancer cell biology across all publications each year (not limited to Nature Index journals).

Technical terms

Forkhead box O (FOXO): A subfamily of forkhead transcription factors that control genes governing cell cycle, apoptosis and metabolism.

Post-translational modification (PTM): Chemical alteration of a protein after synthesis, such as phosphorylation or acetylation, that regulates its function or localisation.

PI3K/AKT pathway: A signalling cascade activated by growth factors that phosphorylates FOXOs, leading to their cytoplasmic retention and inactivation.

Nuclear-cytoplasmic shuttling: The regulated transport of proteins between the nucleus and cytoplasm, determining access to DNA targets.

Tumour suppressor: A gene or protein that prevents uncontrolled cell growth and tumour formation by enforcing cell cycle arrest or apoptosis.

Apoptosis: Programme of organised cell death characterised by DNA fragmentation and membrane blebbing, crucial for eliminating damaged cells.

Metastasis: The process by which cancer cells spread from a primary tumour to establish secondary growths in distant organs.

References

1. Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. Journal of Molecular Signaling (2010).
2. The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor*. Journal of Biological Chemistry (2007).
3. FOXO transcription factor family in cancer and metastasis. Cancer and Metastasis Reviews (2020).
4. Critical role of FOXO3a in carcinogenesis. Molecular Cancer (2018).
5. FOXO Transcription Factors: Their Clinical Significance and Regulation. BioMed Research International (2014).